Table 5:
The Genotypic Distribution According to Adverse Events in Patients Receiving Only Methotrexate Treatment
Adverse Events (-)
(n=13)
Adverse Events (+)
(n=17)
p
1
ns
a
677 CC
7 (53.8%)
9 (52.9%)
677 CT
4 (30.8%)
5 (29.4%)
677 TT
2 (15.4%)
3 (17.6%)
2
ns
a
1298 AA
8 (61.5%)
5 (29.4%)
1298 AC
4 (30.8%)
9 (52.9%)
1298 CC
1 (7.7%)
3 (17.6%)
a
Comparisons in terms of the distibutions of genotypes.
Likelihood ratio test.